Drugs / Autologous Adipose Tissue derived MSCs
Autologous Adipose Tissue derived MSCs
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03000712 | Nov 2016 → May 2020 | osteoarthritis, knee | R-Bio | Completed | Met primary |
| — | NCT02474342 | Jul 2015 → Nov 2016 | rotator cuff syndrome | Seoul National University Hospital | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous adipose tissue derived MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02474342 ↗ |
| Modality | Cell therapy | “Study drugs: Autologous adipose tissue derived MSCs” NCT02474342 ↗ |
| Route | Other | “Injection into the lesion by investigator” NCT02474342 ↗ |